Which drugs were added to FDA’s 2026 first generic approvals list?

FDA’s August 6, 2026 update added 10 first-generic approvals numbered 68 through 77. They included generics referencing Qdolo, Injectafer, Priftin, Sunosi, Xofluza, Tavalisse, and Bosulif, signaling branded exclusivity pressure across pain, anemia, TB, sleep medicine, flu, hematology, and oncology categories.